

Name | Size/Type | Description | Date |
---|---|---|---|
R-BAC consent | 159KB PDF | R-BAC consent | 30 Mar 2024 |
R-Bendamustine consent | 115KB PDF | R-Bendamustine consent | 28 May 2021 |
R-Chlorambucil consent | 110KB PDF | R-Chlorambucil consent | 24 Jun 2022 |
R-CHOP consent | 112KB PDF | R-CHOP consent | 21 Apr 2020 |
R-CVP consent | 113KB PDF | R-CVP consent | 21 Apr 2020 |
R-Cyclophophamide-Dex consent | 113KB PDF | R-Cyclophophamide-Dex consent | 21 Apr 2020 |
R-FC consent | 113KB PDF | R-FC consent | 21 Apr 2020 |
R-GCVP consent | 111KB PDF | R-GCVP consent | 21 Apr 2020 |
R-GemOx consent | 113KB PDF | R-GemOx consent | 26 Feb 2025 |
R-High dose methylprednisolone consent | 110KB PDF | R-High dose methylprednisolone consent | 21 Apr 2020 |
R-Lenalidomide consent | 114KB PDF | R-Lenalidomide consent | 12 Oct 2021 |
R-Venetoclax consent | 113KB PDF | R-Venetoclax consent | 21 Apr 2020 |
Rituximab IV consent | 110KB PDF | Rituximab IV consent | 21 Apr 2020 |
Rituximab Subcutaneous consent | 109KB PDF | Rituximab Subcutaneous consent | 21 Apr 2020 |
Ruxolitinib consent | 112KB PDF | Ruxolitinib consent | 07 Dec 2023 |
All consent forms on this website are for the use of St Luke’s Cancer Alliance staff in respect of St Luke’s Cancer Alliance patients only.
For those who do not work within St Luke’s Cancer Alliance:
Use of this site and any information on it is at your own risk. We do not accept responsibility for the use of any information that may be set out on the website. You assume full responsibility for the use of the information. You may wish to take your own legal advice before using any of the consent forms.
Please note that the consent forms below are not tumour-specific; one consent form may be used to consent patients for more than one St Luke’s Alliance chemotherapy protocol which uses the same combination of chemotherapy.
These consent forms should act as an aide-memoire to health professionals and patients, by providing a check-list of the kind of information which patients should be offered, and by enabling the patient to have a written record of the main points discussed.
The relevant Macmillan/CRUK leaflet(s) should also be provided to each patient before consent. In no way, however, should written information given to the patient be regarded as a substitute for face-to-face discussions with the patient.